[GAVI] Geneva/New York -- Gavi, the Vaccine Alliance and UNICEF welcome the news that a new oral cholera vaccine (OCV), Euvichol-S, has now received WHO prequalification and can be made available to countries around the world. The prequalification of this new product will help EuBiologics, the manufacturer, produce more volumes of vaccine, faster, and at a lower cost - a key step to expanding supply amidst the ongoing acute global upsurge of cholera outbreaks.Today's approval will help increase the overall supply of OCV available
